Bio-Path Holdings Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
13.00
37.00
426
Cost of Goods Sold (COGS) incl. D&A
160.60
170.90
201.80
-
-
426
Gross Income
160.60
170.90
201.80
-
-
426
SG&A Expense
3,108.60
4,371.30
5,282.70
8,284.00
8,592.00
7,556
EBIT
3,269.20
4,542.30
5,484.50
8,475.00
8,966.00
7,982
Unusual Expense
-
-
-
1,713.00
1,934.00
608
Non Operating Income/Expense
0.80
0.30
-
-
-
-
Pretax Income
3,266.00
4,519.90
5,466.80
6,750.00
7,023.00
8,583
Consolidated Net Income
3,266.00
4,519.90
5,466.80
6,750.00
7,023.00
8,583
Net Income
3,266.00
4,519.90
5,466.80
6,750.00
7,023.00
8,583
Net Income After Extraordinaries
3,266.00
4,519.90
5,466.80
6,750.00
7,023.00
8,583
Net Income Available to Common
3,266.00
4,519.90
5,466.80
6,750.00
8,061.00
8,583
EPS (Basic)
0.50
0.50
0.60
0.70
0.80
14.38
Basic Shares Outstanding
7,137.30
8,928.20
8,976.30
9,270.40
10,081.00
597
EPS (Diluted)
0.46
0.51
0.61
0.73
0.80
14.38
Diluted Shares Outstanding
7,137.30
8,928.20
8,976.30
9,270.40
10,081.00
597
EBITDA
3,108.60
4,371.30
5,282.70
8,271.00
8,555.00
7,556
Non-Operating Interest Income
4.00
22.60
17.70
12.00
9.00
7
Preferred Dividends
-
-
-
-
1,038.00
-
About Bio-Path Holdings
View Profile
